News & Updates

In stable post-MI patients without a reduced EF who have been on long-term β-blockers, interrupting the β-blocker treatment instead of continuing it leads to more hospitalizations for CV reasons and does not improve QoL, as shown in the phase III ABYSS trial presented at ESC 2024

Full results of the phase III FINEARTS-HF trial have shown that finerenone cuts the risk of worsening heart failure (HF) events and cardiovascular (CV) death in symptomatic HF with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF).

In patients with acute coronary syndrome, the use of colchicine appears be beneficial in terms of coronary plaque stabilization as assessed on optical coherence tomography, according to a study.

A study has shown that contralateral differences in ankle systolic blood pressure (SBP) and pulse wave velocity (PWV) are predictive of increased mortality risk among older adults.

Adults who engage in leisure-time physical activity (LTPA) may benefit from better cardiometabolic health and are less likely to experience large artery stiffening, suggests a study.

In women with severe symptomatic aortic stenosis (AS), transcatheter aortic valve implantation (TAVI) is superior to conventional surgery in terms of reducing death, stroke, and rehospitalization at 1 year, according to the RHEIA* trial presented at ESC 2024.

A 3‐month online training supervised exercise program appears to produce substantial improvements in quality of life and the cardiovascular and muscular health of patients with Marfan syndrome, according to a study.

Low‐level tragus stimulation, a device-based therapy, appears to yield reductions in blood pressure (BP) in young adults with essential hypertension, as shown in a study.